A Phase 1 clinical trial of TransCon PTH

Trial Profile

A Phase 1 clinical trial of TransCon PTH

Phase of Trial: Phase I

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs TransCon PTH (Primary)
  • Indications Hyperparathyroidism
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Apr 2017 New trial record
    • 03 Apr 2017 Ascendis Pharma plans to initiate this trial in the third quarter of 2017, as reported in a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top